Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1975 Jul;32(1):42–50. doi: 10.1038/bjc.1975.132

Effects of 5-fluorouracil on the cell kinetic and growth parameters of hepatoma 3924A.

C J Kovacs, H A Hopkins, R M Simon, W B Looney
PMCID: PMC2024782  PMID: 169869

Abstract

The effect of 5-fluorouracil (5-FU) on the growth and cellular proliferation of hepatoma 3924A was studied using the following parameters as indices of tumour response: (1) volume measurements, (2) cell kinetic analysis including estimates of both growth and cell loss fractions, (3) changes in tumour histology and (4) tumour DNA content and DNA synthesis. Of a series of single intraperitoneally injected doses (25-300 mg/kg body weight), 150 mg/kg interrupted tumour growth most effectively with minimal toxicity within 168 h, and after 10 days treated tumour volumes were only 42% of untreated tumour size. Doses of 25 mg/kg failed to change the rate of growth while 300 mg/kg exceeded the LD50. Alterations of both tumour cell proliferation and histology developed well in advance of changes observed in growth. A dose of 150 mg/kg body weight blocked the transition of cells from G1 through S for a 24 h interval when cell kinetics were measured by 3H-TdR autoradiography. However, 3H-UdR incorporation into DNA following 5-FU suggested that cellular recovery from the drug was delayed for an additional 24 h. Concurrently, significant losses of tumour tissue and tumour DNA occurred during the first 48 h with an expected increase in both necrotic and connective tissue. During the subsequent 120 h both tumour and necrotic tissue had returned to non-treated levels, while kinetic analysis revealed (a) a slight reduction in the cell cycle time and growth fraction and (b) an increased cell loss factor. The observations from this tumour model system suggest that before using tumour volume or weight as an index of therapeutic response, the relationship between the kinetics of tumour cellularity and tumour volume must be defined.

Full text

PDF
42

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams J. E., Breed N. L., Valenti C. Enhancement of 5 fluorouracil cytotoxicity in synchronized human malignant cells in culture. Tex Rep Biol Med. 1967 Fall;25(3):342–349. [PubMed] [Google Scholar]
  2. BIRNIE G. D., KROEGER H., HEIDELBERGER C. STUDIES OF FLUORINATED PYRIMIDINES. XVIII. THE DEGRADATION OF 5-FLUORO-2'-DEOXYURIDINE AND RELATED COMPOUNDS BY NUCLEOSIDE PHOSPHORYLASE. Biochemistry. 1963 May-Jun;2:566–572. doi: 10.1021/bi00903a031. [DOI] [PubMed] [Google Scholar]
  3. BOSCH L., HARBERS E., HEIDELBERGER C. Studies on fluorinated pyrimidines. V. Effects on nucleic acid metabolism in vitro. Cancer Res. 1958 Apr;18(3):335–343. [PubMed] [Google Scholar]
  4. BURTON K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J. 1956 Feb;62(2):315–323. doi: 10.1042/bj0620315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chadwick M., Rogers W. I. The physiological disposition of 5-fluorouracil in mice bearing solid L1210 lymphocytic leukemia. Cancer Res. 1972 May;32(5):1045–1056. [PubMed] [Google Scholar]
  6. Denekamp J. The relationship between the 'cell loss factor' and the immediate response to radiation in animal tumours. Eur J Cancer. 1972 Jun;8(3):335–340. doi: 10.1016/0014-2964(72)90029-1. [DOI] [PubMed] [Google Scholar]
  7. Denekamp J., Thomlinson R. H. The cell proliferation kinetics of four experimental tumors after acute X-irradiation. Cancer Res. 1971 Sep;31(9):1279–1284. [PubMed] [Google Scholar]
  8. Dethlefsen L. A., Riley R. M. Hydroxyurea effects in the C3H mouse. II. Mammary tumor cell kinetics. Cell Tissue Kinet. 1973 Mar;6(2):173–184. doi: 10.1111/j.1365-2184.1973.tb01606.x. [DOI] [PubMed] [Google Scholar]
  9. Hopkins H. A., Flora J. B., Schimidt R. R. Periodic DNA accumulation during the cell cycle of a thermophilic strain of Chlorella pyrenoidosa. Arch Biochem Biophys. 1972 Dec;153(2):845–849. doi: 10.1016/0003-9861(72)90407-9. [DOI] [PubMed] [Google Scholar]
  10. Kent R. J., Heidelberger C. Fluorinated pyrimidines. XL. The reduction of 5-fluorouridine 5'-diphosphate by ribonucleotide reductase. Mol Pharmacol. 1972 Jul;8(4):465–475. [PubMed] [Google Scholar]
  11. Looney W. B., Mayo A. A., Allen P. M., Morrow J. Y., Morris H. P. A mathematical evaluation of tumour growth curves in rapid, intermediate and slow growing rat hepatomata. Br J Cancer. 1973 Apr;27(4):341–344. doi: 10.1038/bjc.1973.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. MENDELSOHN M. L. Autoradiographic analysis of cell proliferation in spontaneous breast cancer of C3H mouse. III. The growth fraction. J Natl Cancer Inst. 1962 May;28:1015–1029. [PubMed] [Google Scholar]
  13. Madoc-Jones H., Bruce W. R. On the mechanism of the lethal action of 5-fluorouracil on mouse L cells. Cancer Res. 1968 Oct;28(10):1976–1981. [PubMed] [Google Scholar]
  14. Madoc-Jones H., Bruce W. R. Sensitivity of L cells in exponential and stationary phase to 5-fluorouracil. Nature. 1967 Jul 15;215(5098):302–303. doi: 10.1038/215302a0. [DOI] [PubMed] [Google Scholar]
  15. PATTERSON M. S., GREENE R. C. MEASUREMENT OF LOW ENERGY BETA-EMITTERS IN AQUEOUS SOLUTION BY LIQUID SCINTILLATION COUNTING OF EMULSIONS. Anal Chem. 1965 Jun;37:854–857. doi: 10.1021/ac60226a017. [DOI] [PubMed] [Google Scholar]
  16. RICH M. A., BOLAFFI J. L., KNOLL J. E., CHEONG L., EIDINOFF M. L. Growth inhibition of a human tumor cell strain by 5-fluorouracil, 5-fluorouridine, and 5-fluoro-2'-deoxyuridine; reversal studies. Cancer Res. 1958 Jul;18(6):730–735. [PubMed] [Google Scholar]
  17. RUECKERT R. R., MUELLER G. C. Studies on unbalanced growth in tissue culture. I. Induction and consequences of thymidine deficiency. Cancer Res. 1960 Dec;20:1584–1591. [PubMed] [Google Scholar]
  18. Simon R. M., Stroot M. T., Weiss G. H. Numerical inversion of Laplace transforms with application to percentage labeled mitoses experiments. Comput Biomed Res. 1972 Dec;5(6):596–607. doi: 10.1016/0010-4809(72)90039-0. [DOI] [PubMed] [Google Scholar]
  19. Vietti T., Eggerding F., Valeriote F. Combined effect of x radiation and 5-fluorouracil on survival of transplanted leukemic cells. J Natl Cancer Inst. 1971 Oct;47(4):865–870. [PubMed] [Google Scholar]
  20. Wilcox W. S., Griswold D. P., Laster W. R., Jr, Schabel F. M., Jr, Skipper H. E. Experimental evaluation of potenital anticancer agents. XVII. Kinetics of growth and regression after treatment of certain solid tumors. Cancer Chemother Rep. 1965 Aug;47:27–39. [PubMed] [Google Scholar]
  21. Wilcox W. S. Kinetics of cancer cell kill by chemotherapeutic agents in vivo. Natl Cancer Inst Monogr. 1967 Feb;24:257–269. [PubMed] [Google Scholar]
  22. Wolberg W. H. Response of DNA thymine synthesis in human tumor and normal tissue to 5-fluorouracil. Cancer Res. 1972 Jan;32(1):130–132. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES